PET Respiratory Gating to Detect Hepatic Metastasis in Patients With Colon Cancer
NCT01401309 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81
Last updated 2014-02-21
Summary
This study is to examine if there is improved sensitivity in detecting hepatic lesions using respiratory gating and if there is an improvement in confidence defining lesions as benign or malignant.
Conditions
Sponsors & Collaborators
-
Southwestern Regional Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2011-11-30
- Completion
- 2013-03-31
Countries
- United States
Study Locations
More Related Trials
-
Imaging Correlates of Renal Cell Carcinoma Biological Features
NCT01665703 ·Status: COMPLETED ·Phase: NA
-
The Value of Diffusion-weighted Imaging in Evaluating the Early Efficacy of Liver Metastasis in Colorectal Cancer
NCT03088163 ·Status: UNKNOWN ·Phase: NA
-
PET-CT Predicting Lymph Nodes Metastasis
NCT05970913 ·Status: ACTIVE_NOT_RECRUITING
-
Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases
NCT00592462 ·Status: COMPLETED
-
An Investigational Scan (MR DENSE) in Detecting Early Chemotherapy-Related Liver Injury Before Surgery in Patients With Resectable Colorectal Liver Metastases
NCT05059717 ·Status: WITHDRAWN ·Phase: NA
-
PET Avidity in Cachexia-Inducing Lung and Gastrointestinal Tumors
NCT03568019 ·Status: ACTIVE_NOT_RECRUITING
-
PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection
NCT01395030 ·Status: COMPLETED ·Phase: PHASE2
-
FDG Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic Prostate Cancer
NCT00282906 ·Status: COMPLETED ·Phase: NA
-
Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions
NCT02156739 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
NCT06877949 ·Status: RECRUITING ·Phase: NA
-
Correlation of Pre- and Post-operative Cancer Imaging Techniques
NCT04776291 ·Status: COMPLETED ·Phase: NA
-
Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract
NCT04069299 ·Status: COMPLETED
-
PET/CT: Role in Detecting Unknown Primary Head and Neck Cancer
NCT00656760 ·Status: COMPLETED ·Phase: NA
-
[68Ga]Ga-NOTA-RW102 PET Imaging in the Diagnosis of PD-L1-expressing Lung Cancer
NCT06165874 ·Status: RECRUITING ·Phase: NA
-
Breathing Synchronized PET/CT Scans for the Detection of Malignant Lung & Liver Lesions and Assessment of Tumor Glycolysis
NCT01052766 ·Status: TERMINATED ·Phase: NA
-
Role of 18F-FDG PET/CT in Gastric Cancer
NCT05687552 ·Status: UNKNOWN
-
18F-FDG PET Metabolic Phenotype in Evaluating Therapeutic Response for Breast Cancer Patients With Bone Metastases.
NCT01927939 ·Status: UNKNOWN
-
Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers
NCT01421953 ·Status: COMPLETED ·Phase: NA
-
Glutamine PET Imaging Colorectal Cancer
NCT03275974 ·Status: TERMINATED ·Phase: PHASE1
-
The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis.
NCT06597526 ·Status: RECRUITING
-
The Role of PET/MRI in Predicting the Outcome of Definitive Chemoradiotherapy for Esophageal Cancer Patients
NCT05855278 ·Status: COMPLETED ·Phase: NA
-
Gadoxetate Abbreviated MRI in Metastatic Colorectal Cancer
NCT05314400 ·Status: RECRUITING ·Phase: NA
-
Target-specific immunoPET Imaging of Digestive System Carcinoma
NCT06715839 ·Status: RECRUITING ·Phase: NA
-
Use of Integrated PET/CT as a First Line Staging and Re-staging Technique in Oncologic Patient.
NCT06168877 ·Status: COMPLETED
-
Evaluation of the Signa Excite 3.0 T MRI Excite for Detection and Characterization of Liver Lesions
NCT00527891 ·Status: COMPLETED